179 related articles for article (PubMed ID: 25999712)
1. Delivery of microRNA-146a with polyethylenimine nanoparticles inhibits renal fibrosis in vivo.
Morishita Y; Imai T; Yoshizawa H; Watanabe M; Ishibashi K; Muto S; Nagata D
Int J Nanomedicine; 2015; 10():3475-88. PubMed ID: 25999712
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-196a/b Mitigate Renal Fibrosis by Targeting TGF-β Receptor 2.
Meng J; Li L; Zhao Y; Zhou Z; Zhang M; Li D; Zhang CY; Zen K; Liu Z
J Am Soc Nephrol; 2016 Oct; 27(10):3006-3021. PubMed ID: 26940097
[TBL] [Abstract][Full Text] [Related]
3. E-selectin-targeting delivery of microRNAs by microparticles ameliorates endothelial inflammation and atherosclerosis.
Ma S; Tian XY; Zhang Y; Mu C; Shen H; Bismuth J; Pownall HJ; Huang Y; Wong WT
Sci Rep; 2016 Mar; 6():22910. PubMed ID: 26956647
[TBL] [Abstract][Full Text] [Related]
4. Effect of miR-146a/bFGF/PEG-PEI Nanoparticles on Inflammation Response and Tissue Regeneration of Human Dental Pulp Cells.
Liu L; Shu S; Cheung GS; Wei X
Biomed Res Int; 2016; 2016():3892685. PubMed ID: 27057540
[TBL] [Abstract][Full Text] [Related]
5. Amphiphilic core-shell nanoparticles containing dense polyethyleneimine shells for efficient delivery of microRNA to Kupffer cells.
Liu Z; Niu D; Zhang J; Zhang W; Yao Y; Li P; Gong J
Int J Nanomedicine; 2016; 11():2785-97. PubMed ID: 27366061
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of fasudil on renal interstitial fibrosis induced by unilateral ureteral obstruction.
Baba I; Egi Y; Utsumi H; Kakimoto T; Suzuki K
Mol Med Rep; 2015 Dec; 12(6):8010-20. PubMed ID: 26498136
[TBL] [Abstract][Full Text] [Related]
7. Role of microRNA-146a in regulation of fibrosis in orbital fibroblasts from patients with Graves' orbitopathy.
Jang SY; Park SJ; Chae MK; Lee JH; Lee EJ; Yoon JS
Br J Ophthalmol; 2018 Mar; 102(3):407-414. PubMed ID: 29101123
[TBL] [Abstract][Full Text] [Related]
8. Pre-administration of PepFect6-microRNA-146a nanocomplexes inhibits inflammatory responses in keratinocytes and in a mouse model of irritant contact dermatitis.
Urgard E; Lorents A; Klaas M; Padari K; Viil J; Runnel T; Langel K; Kingo K; Tkaczyk E; Langel Ü; Maimets T; Jaks V; Pooga M; Rebane A
J Control Release; 2016 Aug; 235():195-204. PubMed ID: 27269729
[TBL] [Abstract][Full Text] [Related]
9. miR-146a-5p acts as a negative regulator of TGF-β signaling in skeletal muscle after acute contusion.
Sun Y; Li Y; Wang H; Li H; Liu S; Chen J; Ying H
Acta Biochim Biophys Sin (Shanghai); 2017 Jul; 49(7):628-634. PubMed ID: 28510617
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-146a-5p Negatively Regulates Pro-Inflammatory Cytokine Secretion and Cell Activation in Lipopolysaccharide Stimulated Human Hepatic Stellate Cells through Inhibition of Toll-Like Receptor 4 Signaling Pathways.
Chen Y; Zeng Z; Shen X; Wu Z; Dong Y; Cheng JC
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399683
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-146a in Human and Experimental Ischemic AKI: CXCL8-Dependent Mechanism of Action.
Amrouche L; Desbuissons G; Rabant M; Sauvaget V; Nguyen C; Benon A; Barre P; Rabaté C; Lebreton X; Gallazzini M; Legendre C; Terzi F; Anglicheau D
J Am Soc Nephrol; 2017 Feb; 28(2):479-493. PubMed ID: 27444565
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor α-mediated transforming growth factor-β1/Smad signaling pathway.
Kim D; Lee AS; Jung YJ; Yang KH; Lee S; Park SK; Kim W; Kang KP
Nephrol Dial Transplant; 2014 Nov; 29(11):2043-53. PubMed ID: 25031017
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic activity of the histone deacetylase inhibitor SB939 on renal fibrosis.
Kang SW; Lee SM; Kim JY; Kim SY; Kim YH; Kim TH; Kang MS; Jang WH; Seo SK
Int Immunopharmacol; 2017 Jan; 42():25-31. PubMed ID: 27855304
[TBL] [Abstract][Full Text] [Related]
14. Polymeric nanoparticles for the delivery of miRNA to treat Chronic Obstructive Pulmonary Disease (COPD).
Mohamed A; Kunda NK; Ross K; Hutcheon GA; Saleem IY
Eur J Pharm Biopharm; 2019 Mar; 136():1-8. PubMed ID: 30615927
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma.
Kunz M; Brandl M; Bhattacharya A; Nobereit-Siegel L; Ewe A; Weirauch U; Hering D; Reinert A; Kalwa H; Guzman J; Weigelt K; Wach S; Taubert H; Aigner A
J Nanobiotechnology; 2020 Nov; 18(1):173. PubMed ID: 33228711
[TBL] [Abstract][Full Text] [Related]
16. Cationic microRNA-delivering nanocarriers for efficient treatment of colon carcinoma in xenograft model.
Liang G; Zhu Y; Jing A; Wang J; Hu F; Feng W; Xiao Z; Chen B
Gene Ther; 2016 Dec; 23(12):829-838. PubMed ID: 27482839
[TBL] [Abstract][Full Text] [Related]
17. Silencing of microRNA-132 reduces renal fibrosis by selectively inhibiting myofibroblast proliferation.
Bijkerk R; de Bruin RG; van Solingen C; van Gils JM; Duijs JM; van der Veer EP; Rabelink TJ; Humphreys BD; van Zonneveld AJ
Kidney Int; 2016 Jun; 89(6):1268-80. PubMed ID: 27165825
[TBL] [Abstract][Full Text] [Related]
18. Rabies virus glycoprotein (RVG29)-linked microRNA-124-loaded polymeric nanoparticles inhibit neuroinflammation in a Parkinson's disease model.
Gan L; Li Z; Lv Q; Huang W
Int J Pharm; 2019 Aug; 567():118449. PubMed ID: 31226473
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-κB-driven inflammation and atherosclerosis.
Li K; Ching D; Luk FS; Raffai RL
Circ Res; 2015 Jun; 117(1):e1-e11. PubMed ID: 25904598
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of Cardiac Dysfunction in Polymicrobial Sepsis by MicroRNA-146a Is Mediated via Targeting of IRAK1 and TRAF6 Expression.
Gao M; Wang X; Zhang X; Ha T; Ma H; Liu L; Kalbfleisch JH; Gao X; Kao RL; Williams DL; Li C
J Immunol; 2015 Jul; 195(2):672-82. PubMed ID: 26048146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
